Effects of a multifaceted *teleguided* pain care programs in patients with cancer
Completed
- Conditions
- cancer pain10027656oncologic pain
- Registration Number
- NL-OMON38991
- Lead Sponsor
- niversiteit Maastricht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 174
Inclusion Criteria
- Diagnosis of cancer
- Patients who are under (palliative) anti-tumour treatment in a day clinic or outpatient clinic, or patients who have no treatment options available anymore
- Cancer (treatment related) pain > 2 weeks
- Pain is defined as a patient reported pain score * 4 on a numerical rating scale (NRS, scale 0-10)
- Living at home
Exclusion Criteria
- Expected life expectancy < 3 months
- Chronic non-cancer pain
- Known cognitive impairments
- Participation in other studies that interfere with this study
- Not being able to read and understand the Dutch language
- Reduced vision
- Non-reachable by phone
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcomes of the effect evaluation are pain intensity and quality of<br /><br>life.<br /><br><br /><br>- Pain intensity is measured with the Brief Pain Inventory (BPI), an instrument<br /><br>frequently used to monitor pain in the clinical and research setting (Cleeland<br /><br>1994; Jensen, 2003).<br /><br>- Quality of life is measured with the EORTC Quality of Life Questionnaire<br /><br>(EORTC-QLQ-C30 version 3). This instrument is cancer specific,<br /><br>multi-dimensional and appropriate for self-administration. The EORTC-QLQ-C30<br /><br>has shown acceptable levels of reliability and validity (Aaronson et al.,<br /><br>1993). </p><br>
- Secondary Outcome Measures
Name Time Method